NCT06336109

Brief Summary

This interventional study aims to test the effects of sleep disruption on pain sensitivity and biomechanics in healthy individuals during experimental knee and shoulder pain. The main question the study aims to answer is: 1\) Does sleep fragmentation increase experimental knee and shoulder pain and what are the underlying mechanisms? Participants will receive two injections a) Hypertonic saline (painful) in the knee and b) hypertonic saline (painful) in the upper arm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable pain

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 26, 2024

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

March 22, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 28, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

October 2, 2025

Status Verified

April 1, 2024

Enrollment Period

1.2 years

First QC Date

March 22, 2024

Last Update Submit

September 30, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Knee Pain intensity (NRS 0-10)

    Pain during intervention is measured continuously every 30 seconds on a numeric rating scale from 0 'no pain' to 10 'the worst pain imaginable'

    Baseline (day 1) and follow-up (day 4)

  • Shoulder Pain intensity (NRS 0-10)

    Pain during intervention is measured continuously every 30 seconds on a numeric rating scale from 0 'no pain' to 10 'the worst pain imaginable'

    Baseline (day 1) and follow-up (day 4)

Secondary Outcomes (8)

  • Pain sensitivity

    Baseline (day 1) and follow-up (day 4)

  • The Pittsburgh Sleep Quality Index score

    Baseline (day 1) and follow-up (day 4)

  • The Pain catastrophizing Scale score

    Baseline (day 1) and follow-up (day 4)

  • The Hospital Anxiety and Depression Scale score

    Baseline (day 1) and follow-up (day 4)

  • The Knee injury and Osteoarthritis Outcome Score

    Baseline (day 1) and follow-up (day 4)

  • +3 more secondary outcomes

Other Outcomes (2)

  • Quality of sleep (NRS 0-100)

    Baseline (day 1), day 2, day 3 and follow-up (day 4)

  • Level of rest (NRS 0-100)

    Baseline (day 1), day 2, day 3 and follow-up (day 4)

Study Arms (1)

Experimental Knee Pain and Shoulder Pain

EXPERIMENTAL

Injection to the infrapatellar fat pad. Will always be administered first. Injection to the deltoid muscle. Will always be administered last.

Other: Hypertonic saline knee and shoulder injection

Interventions

0.25 mL injection with hypertonic saline (7%) in the infrapatellar fat pad. 1.2 mL injection with hypertonic saline (7%) in the deltoid muscle.

Experimental Knee Pain and Shoulder Pain

Eligibility Criteria

Age18 Years - 45 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men and women aged 18-45 years
  • Must have a smartphone available during the experiment

You may not qualify if:

  • Pregnancy
  • Drug addiction, defined as the use of cannabis, opioids, or other drugs
  • Previous or current neurologic or musculoskeletal illnesses
  • Current pain
  • Lack of ability to cooperate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aalborg University

Aalborg, North Denmark, 9000, Denmark

Location

MeSH Terms

Conditions

PainParasomnias

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Kristian KS Petersen

    Aalborg University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate professor

Study Record Dates

First Submitted

March 22, 2024

First Posted

March 28, 2024

Study Start

January 26, 2024

Primary Completion

April 1, 2025

Study Completion

September 1, 2025

Last Updated

October 2, 2025

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations